Browsing by Author Reynolds, John

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2012All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)Bradstock, Kenneth; Hertzberg, Mark; Iland, Harry; Browett, Peter; Catalano, Alberto; Collins, Marnie; Dilulio, J.; et al, various; Firkin, Frank; Grigg, Andrew P.; Hugman, Amanda; Reynolds, John; Supple, Shane; Tiley, Campbell; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineAll-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4), Blood, vol.120, 8, 2012,pp 1570-1580
2006PAMIDRONATE REDUCES BONE LOSS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.Bradstock, Kenneth; Ebeling, Peter R; Grigg, Andrew P.; Herrmann, Richard; Hui, C.; Reynolds, John; Schwarer, Anthony; Shuttleworth, P; Szer, J.; Western Clinical School: Westmead Millennium InstitutePAMIDRONATE REDUCES BONE LOSS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION., The Journal of Clinical Endocrinology & Metabolism (2005), vol.91,(10),2006,pp 3835-3843
2007A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioningBradstock, Kenneth; Gibson, John; Bardy, P G; Grigg, Andrew P.; Kennedy, Gregor; Koelmeyer, R L; Reynolds, John; Roberts, A W; Shuttleworth, P; Szer, J.; To, L B; Western Clinical School: Westmead Millennium Institute; Central Clinical School: MedicineA prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning, Biology Of Blood And Marrow Transplantation, vol.13,(5),2007,pp 560-567
2006Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.Kirk, Judy; Antill, Yoland C.; Bogtstra, Tarli; Di Iulio, Juliana; Dudding, Tracy; Phillips, Kelly-Anne; Reynolds, John; Tucker, Katherine M.; Wong, Shirley; Young, Mary-Anne; Western Clinical School: Westmead Millennium InstituteRisk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer., European Journal of Cancer (2005), vol.42,(5),2006,pp 621-628
2015Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trialBradstock, Kenneth; Hertzberg, Mark; Iland, Harry; Browett, Peter; Campbell, Lynda J.; Catalano, Alberto; Collins, Marnie; Di Iulio, Juliana L.; et al, Various; Firkin, Frank; Grigg, Andrew P.; Hugman, Amanda; Reynolds, John; Supple, Shane; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineUse of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial, The Lancet Haematology, vol.2, 9, 2015,pp e357-e366